Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients—a single-center retrospective study
Regidor, Bernard, Goldwater, Marissa-Skye, Wang, Jessica, Bujarski, Sean, Swift, Regina, Eades, Benjamin, Emamy-Sadr, Marsiye, Eshagian, Shahrooz, Schwartz, Gary, Spektor, Tanya M., Berenson, James R.
Published in Annals of hematology (01.08.2021)
Published in Annals of hematology (01.08.2021)
Get full text
Journal Article